Skip to Content

Cabazitaxel

In the US, Cabazitaxel (cabazitaxel systemic) is a member of the drug class mitotic inhibitors and is used to treat Prostate Cancer.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01CD04

CAS registry number (Chemical Abstracts Service)

0183133-96-2

Chemical Formula

C45-H57-N-O14

Molecular Weight

835

Therapeutic Categories

Cytostatic agent

Microtubule inhibitor

Taxane

Chemical Names

(2α,5β,7β,10β,13α)-4-acetoxy-13-({(2R,3S)-3-[(tertbutoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoyl}oxy)-1-hydroxy-7,10-dimetoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate-propan-2-one (1:1)

1-hydroxy-7β,10β-dimetyoxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoate] (WHO)

Foreign Names

  • Cabazitaxelum (Latin)
  • Cabazitaxel (German)
  • Cabazitaxel (French)
  • Cabazitaxel (Spanish)

Generic Names

  • Cabazitaxel (OS: USAN, BAN)
  • RPR 116258A (IS)
  • Taxoid XRP6258 (IS)
  • TXD 258 (IS)
  • XRP 6258 (IS)

Brand Names

  • Jetvana
    Sanofi-aventis, Czech Republic
  • Jevtana
    Sanofi, Dominican Republic; Sanofi, United Kingdom; Sanofi, Guatemala; Sanofi, Ireland; Sanofi, Panama; Sanofi, Sweden; Sanofi Aventis, Chile; Sanofi Aventis, Spain; Sanofi Oy, Finland; Sanofi-Aventis, Argentina; Sanofi-Aventis, Austria; Sanofi-Aventis, Australia; Sanofi-Aventis, Bosnia & Herzegowina; Sanofi-Aventis, Belgium; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Colombia; Sanofi-Aventis, Costa Rica; Sanofi-Aventis, Germany; Sanofi-Aventis, Denmark; Sanofi-Aventis, France; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Honduras; Sanofi-Aventis, Indonesia; Sanofi-Aventis, Iceland; Sanofi-Aventis, Italy; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Mexico; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Norway; Sanofi-Aventis, Poland; Sanofi-Aventis, Portugal; Sanofi-Aventis, Romania; Sanofi-Aventis, Singapore; Sanofi-Aventis, Slovakia; Sanofi-Aventis, El Salvador; Sanofi-Aventis, Thailand; Sanofi-Aventis Groupe, Slovenia

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide